Prof Neil Gross is a dedicated surgeon and scientist with a passion for service, individualised cancer care and cancer research. Prof Gross completed a head and neck surgery and oncology fellowship at Memorial Sloan Kettering Cancer Centre and has since developed an international reputation as a thought-leader in head and neck cancer. He has published extensively and has served in many service and leadership roles nationally and internationally. He currently serves as Professor in the Department of Head and Neck Surgery and Medical Director of Perioperative Surgical Services at MD Anderson Cancer Center. His clinical and research interests focus on improving functional outcomes using transoral robotic surgery (TORS) for HPV-associated oropharynx cancer and neoadjuvant approaches to head and neck cancers including aggressive cutaneous squamous cell carcinoma (CSCC). Prof Gross is an expert in the development and execution of surgeon-led clinical trials, including a registrational-intent randomized phase 3 trial using neoadjuvant immunotherapy for advanced, resectable CSCC.